Comparing two creams for eczema in young people
Part of Genetic & congenital, Immune system & allergy, Skin clinical trials.
This study tests two different prescription creams, crisaborole and tacrolimus, to see which works better for treating eczema (also called atopic dermatitis) in people aged 5 to 25. If you or your child have mild to moderate eczema, this trial may help find a more effective treatment option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with eczema (atopic dermatitis) by a doctor using standard criteria.
- You are between 5 and 25 years old.
- Your eczema is rated as mild or moderate by a doctor (not severe).
- You have not used any eczema creams on the affected areas in the last 14 days, and no oral or injected eczema medication in the past month.
- You are not pregnant or breastfeeding (if applicable).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new dermocosmetic cream for children with eczema. It looks at how well the cream works and how gentle it is on the skin, after the child uses a prescribed steroid cream to calm a flare-up.
This trial tests a daily pill called Abrocitinib to see if it can help children ages 6 to 11 with moderate-to-severe eczema that hasn't gotten better with creams or ointments. Eczema (also called atopic dermatitis) causes itchy, red skin, and this medicine might calm the immune response to reduce itching and rashes.
This Phase 2 study tests different treatments for atopic dermatitis (eczema) by looking at changes in skin health. It may help people find safer, more effective ways to control moderate to severe eczema and related skin infections.
This study compares two creams for treating mild to moderate eczema in children: crisaborole 2% and tacrolimus 0.1%. It aims to see which one is more effective and safe for your child.
This study compares two prescription creams used to treat mild to moderate eczema (atopic dermatitis) in people aged 2 and older. The goal is to see which cream is safer and works better for reducing symptoms like itching and redness.
This study compares two prescription creams, tacrolimus and crisaborole, to see which works better and is safer for treating mild to moderate eczema over 8 weeks. Both creams are applied to the skin and are alternatives to steroids.
Hear when a new Eczema trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.